Fig. 3
From: Inhibition of monocarboxylate transporter 1 suppresses the proliferation of glioblastoma stem cells
Effect of pHMBS on non-CSCs and CSCs. a Cells were treated with pHMBS (U-251 MG: 200–360 μM, U-87 MG: 100–260 μM) or vehicle for 72 h (n = 3, mean ± SEM; *p < 0.05, **p < 0.01 vs. non-CSC of each concentration). b The number and size of spheres treated for 6 days with various concentrations of pHMBS. Scale bars 300 μm. c The intracellular lactate density (nmol/1.0 × 104 cells) of non-CSCs or CSCs treated with pHMBS for 72 h (non-CSCs) or 6 days (CSCs). These data are representative of two independent experiments. CSC cancer stem cell